Enterprise-grade AI startup Prezent announced this week that biopharmaceutical executive Janet Dorling is joining its Board of Directors.
The communications startup, powered by Astrid (a contextually intelligent AI that leverages industry-specific Specialized Presentation Models) allows enterprises to create effective, brand-aligned presentations.
Said Gorling, “I’ve seen firsthand how much time and money organizations can waste on ineffective communication. In biopharma, where the stakes are so high, clarity and speed can’t be optional—they’re essential. The intelligent and contextually aware platform that Prezent has created is a total reinvention for how companies scale compelling, consistent messaging across the enterprise.”
As Senior Vice President at Gilead Sciences, a biopharmaceutical company focused on advancing innovative treatments for critical diseases, Dorling brings more than 2 decades of experience at both startups and enterprises.
She also currently serves on the Advisory Board for the Robinson Life Science, Business, and Entrepreneurship Program at UC Berkeley.
“Life sciences companies spend hundreds of millions on agencies and consultancies to do work that can easily be done with Prezent’s platform. Software-plus-services solutions like Prezent offer a smarter, more scalable alternative. I’m incredibly excited to join the Board and help bring this solution to more teams across the industry—and eventually, many others,” added the executive.
Dorling’s connection to Prezent is rooted in years of firsthand experience with its platform.
“This is about freeing teams to focus on the story, not the slide design,” Dorling said. “Prezent gives you time back. It empowers better decisions, clearer communication, and ultimately better outcomes—for the business and the patients we serve.”
Dorling’s appointment marks the latest milestone in the company’s roadmap to support productivity and boost enterprise performance by tackling ineffective business communication.
“Janet is the exact kind of leader every company dreams of having on its Board,” said Rajat Mishra, Founder and CEO of Prezent.
“She deeply understands the nuances of biopharma, sees the impact Prezent can have across functions and regions, and brings an operator’s perspective to scaling adoption. We’re thrilled to have her on this journey with us,” concluded the founder.
Featured photo of Rajat Mishra and Janet Dorling
